Refractory Symptoms
Showing 1 - 25 of >10,000
Refractory Reflux Esophagitis Trial in Xi'an (Trimebutine Maleate, rabeprazole)
Withdrawn
- Refractory Reflux Esophagitis
- Trimebutine Maleate
- rabeprazole
-
Xi'an, Shaanxi, ChinaXijing Hosipital of Digestive Disease
Jan 30, 2023
Impact of ATP on Laryngeal Symptoms, Hypersensitivity and
Recruiting
- Chronic Refractory Cough
- Laryngeal sensitivity testing
-
Copenhagen, DenmarkBispebjerg Hospital
Nov 28, 2022
Cardiomyopathy, Hypertrophic Trial in London (Active pacing, Back-up pacing)
Recruiting
- Cardiomyopathy, Hypertrophic
- Active pacing
- Back-up pacing
-
London, Thames, United KingdomBarts Heart Centre
Oct 7, 2021
Multiple Sclerosis, Relapsing-Remitting Trial in Lugano (StimRouter®, Self-activated and self-controlled neuromodulation device
Active, not recruiting
- Multiple Sclerosis, Relapsing-Remitting
- StimRouter®, Self-activated and self-controlled neuromodulation device (Bioness Inc, CE0086).
-
Lugano, Ticino, SwitzerlandOspedale Regionale di Lugano, Neurocenter of Southern Switzerlan
Mar 22, 2022
Overactive Bladder Trial in Birmingham (Mirabegron 50 MG, Posterior Tibial Nerve Stimulation (PTNS))
Recruiting
- Overactive Bladder
- Mirabegron 50 MG
- Posterior Tibial Nerve Stimulation (PTNS)
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Nov 22, 2021
Parkinson's Disease Trial in Charlottesville (ExAblate Transcranial System)
Active, not recruiting
- Parkinson's Disease
- ExAblate Transcranial System
-
Charlottesville, VirginiaUniversity of Virginia
Dec 19, 2022
Refractory Schizophrenia Trial in Pasadena (NaBen®, Placebo)
Recruiting
- Refractory Schizophrenia
- NaBen®
- Placebo
-
Pasadena, CaliforniaFor additional information regarding investigative sites for thi
Sep 10, 2021
Refractory Angina Trial in Basildon, Bournemouth, London (Coronary Sinus Reducer, Placebo Procedure)
Recruiting
- Refractory Angina
- Coronary Sinus Reducer
- Placebo Procedure
-
Basildon, United Kingdom
- +4 more
Aug 25, 2021
Refractory Angina Trial in Sao Paulo (Allopurinol 300 MG, Placebo oral tablet)
Recruiting
- Refractory Angina
- Allopurinol 300 MG
- Placebo oral tablet
-
Sao Paulo, SP, BrazilHeart Institute
Feb 23, 2021
Schizophrenia Trial in Austin (1 Hz rTMS, 10 Hz rTMS)
Terminated
- Schizophrenia
- 1 Hz rTMS
- 10 Hz rTMS
-
Austin, TexasSeton Brain and Spine Institute "Brain Stimulation Laboratory"
Mar 16, 2021
Multiple Sclerosis Trial in Lugano (eCoin)
Withdrawn
- Multiple Sclerosis
- eCoin
-
Lugano, Ticino, SwitzerlandOspedale Regionale di Lugano, Neurocenter of Southern Switzerlan
Feb 2, 2021
Parkinson's Disease Trial in United States (ExAblate Transcranial System)
Completed
- Parkinson's Disease
- ExAblate Transcranial System
-
Stanford, California
- +4 more
Dec 20, 2021
OCD, Obsessive-compulsive Disorders and Symptoms Trial in Belmont (Cognitive bias modification for interpretation bias,
Recruiting
- Obsessive-Compulsive Disorder
- Obsessive-compulsive Disorders and Symptoms
- Cognitive bias modification for interpretation bias
- +3 more
-
Belmont, MassachusettsMcLean Hospital
Aug 31, 2021
Multiple Myeloma Trial in Worldwide (Eftozanermin alfa, Bortezomib, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Eftozanermin alfa
- +2 more
-
Atlanta, Georgia
- +18 more
Oct 12, 2022
Gastroesophageal Reflux Trial in Redwood City (Fexofenadine, Placebo - Cap)
Terminated
- Gastroesophageal Reflux
- Fexofenadine
- Placebo - Cap
-
Redwood City, CaliforniaStanford Health Care
Jan 27, 2021
Cancer Patients Discomfort Symptoms
Completed
- Refractory Cancer Pain
- Intrathecal Analgesia
-
Montpellier, FranceUhmontpellier
Jul 28, 2020
Gastroesophageal Reflux Disease (GERD) Trial in Redmond (EsophyX System with SerosaFuse fasteners, PPI)
Completed
- Gastroesophageal Reflux Disease (GERD)
- EsophyX System with SerosaFuse fasteners
- PPI
-
Redmond, WashingtonEndoGastric Solutions
Nov 6, 2020
Parkinson Disease Trial in Worldwide (ExAblate Pallidotomy, Sham ExAblate Pallidotomy)
Active, not recruiting
- Parkinson Disease
- ExAblate Pallidotomy
- Sham ExAblate Pallidotomy
-
Stanford, California
- +19 more
Nov 5, 2020
Prevalence of IEM Among Upper GIT Symptoms
Not yet recruiting
- Esophageal Motility Disorders
- (no location specified)
Jun 12, 2023
Lyme Arthritis, Lyme Disease, Arthritis Trial in Pittsburgh (Naproxen, Acetaminophen)
Recruiting
- Lyme Arthritis
- +2 more
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
Dec 2, 2022
Dermatitis Herpetiformis Trial in Tampere (Assessment of prognosis of refractory dermatitis herpetiformis. No intervention)
Enrolling by invitation
- Dermatitis Herpetiformis
- Assessment of prognosis of refractory dermatitis herpetiformis. No intervention
-
Tampere, FinlandTampere University Hospital
Aug 18, 2023
Schizophrenia Trial in Tianjin (Transcranial alternating Current Stimulation (tACS)-active, Transcranial Alternating Current
Completed
- Schizophrenia
- Transcranial alternating Current Stimulation (tACS)-active
- Transcranial Alternating Current Stimulation (tACS)-sham
-
Tianjin, Tianjin, ChinaTianjin Anding Hospital
Oct 5, 2022
Movement Disorders, Essential Tremor, Holmes Tremor Trial in Toronto (Transcranial ExAblate System)
Active, not recruiting
- Movement Disorders
- +8 more
- Transcranial ExAblate System
-
Toronto, Ontario, Canada
- +1 more
Dec 19, 2022
Treatment-resistant Schizophrenia Trial in Columbus (Clozapine, Antipsychotics,Other (non-Clozapine))
Not yet recruiting
- Treatment-resistant Schizophrenia
- Clozapine
- Antipsychotics,Other (non-Clozapine)
-
Columbus, OhioOhio State University Harding Hospital
Feb 22, 2023
SLE (Systemic Lupus), Sjogren's Syndrome, Systemic Scleroderma Trial in Taiyuan (CD19 targeted CAR-T cells)
Recruiting
- SLE (Systemic Lupus)
- +4 more
- CD19 targeted CAR-T cells
-
Taiyuan, Shanxi, ChinaShanxi Bethune Hospital
Sep 25, 2023